Professionnels de la santé – e-Learning

Objectifs d'apprentissage :

• Décrire les caractéristiques du virus de la grippe ainsi que l’effet du glissement antigénique
• Comparer la méthode de production et l’efficacité du nouveau vaccin cellulaire avec celles des vaccins cultivés dans des œufs
• Mise en œuvre de méthodes d’optimisation des services de vaccination

Pour participer à ce programme de formation continue et obtenir 1 UFC, vous devez être un utilisateur enregistré de RéseauSantéCanadien.ca et de son site d'apprentissage compagnon, eCortex.ca. L'enregistrement est gratuit et facile. Visitez www.canadianhealthcarenetwork.ca pour vous inscrire.

Pour vous inscrire, allez au site Internet de eCortex.ca.

This training module is intended as a refresher on how to administer the flu vaccine. The module can be completed within 30 minutes.

The iMD Patient Engagement Platform is a web-based patient education platform that is available on any device with internet. iMD Health enables healthcare providers to bring their patient sessions to life through the seamless integration of professionally-vetted diagrams, educational resources, brochures and videos covering over 1,800 medical conditions, procedures and treatment options.

To get your account, visit app.imdhealth.com/signup.

Les infections endémiques de l’influenza ont été atténuées durant la pandémie de COVID-19; cependant, la vaccination antigrippale demeure un outil essentiel de santé publique, car elle permet de réduire davantage les éclosions de grippe. Ce programme de formation résume les principales recommandations du Comité Consultatif National de l’Immunisation (CCNI) concernant la vaccination antigrippale et passe en revue les vaccins actuellement disponibles au Canada, ainsi que les différences entre eux. Ce programme a comme objectif général de rehausser la confiance des cliniciens dans la mise en œuvre des recommandations du CCNI durant la saison grippale 2021-2022.

Pour vous inscrire, allez au site Internet de mdBriefCase.

N. meningitidis serogroup B strain is the most prevalent form of invasive meningococcal disease in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. With the availability of vaccines to protect against the different serogroups, it is important for clinicians to educate patients on the potential risks of meningococcal infection and the benefits of immunization. This program will review the clinical consequences of meningococcal type B infection, the different vaccine options and how it can be integrated into practice.

Pour vous inscrire, allez au site Internet de mdBriefCase.

Learning Objectives:

• Describe traveller cases that can be managed by primary care pharmacists.
• Educate the traveller regarding anticipated health risks and methods for prevention, based on risk assessment.
• Recommend the appropriate immunizations, and over‐the‐counter products for travelling patients who can be managed by primary care pharmacists.
• Identify high‐risk patients or destinations that require a referral to a travel medicine specialist or travel clinic.

Pour vous inscrire, allez au site Internet de eCortex.ca.

L’objectif de ce programme est d’aider les pharmaciens à formuler des recommandations sur la santé avant le voyage et de conseiller les patients sur les stratégies de prévention appropriées pour réduire les risques de maladies courantes liées aux voyages et pour prévenir les maladies transmises par les moustiques pendant le voyage. Le programme vise également […]

Pour vous inscrire, allez au site Internet de dBriefCase.

Alors que le nombre de voyages à l’international ne cesse d’augmenter, les praticiens en soins de santé jouent un rôle de plus en plus important pour protéger les voyageurs canadiens contre les maladies liées aux voyages. Ce programme de formation a pour but d’aider les praticiens de soins de santé primaires à émettre des recommandations […]

Pour vous inscrire, allez au site Internet de mdBriefCase.

This activity is intended for primary care physicians and infectious disease specialists.

The goal of this activity is for learners to be more knowledgeable about the epidemiology, clinical presentation, and burden of chikungunya virus.

Upon completion of this activity, participants will have increased knowledge regarding:

• The epidemiology of chikungunya
• The disease burden of chikungunya
• The diagnosis of chikungunya

Pour vous inscrire, allez au site Internet de Medscape.

This webinar will focus on immunization information-gathering and decision-making practices in vulnerable refugee and immigrant populations in the city of Edmonton, Alberta. Ms. Stephanie Kowal will present key findings and recommendations from her study on the prairies focusing particularly on the potential impact that using cultural brokers can have on the success of creating access to immunization services and promoting immunization uptake.

Visitez NCCID.adobeconnect.com pour écouter le webinaire.

After viewing this webinar, participants will be better to:

• Review the current state of the COVID-19 pandemic in terms of cases, hospitalizations and deaths
• Discuss the impact of the omicron subvariant BA.2 as public health protections are removed
• Counsel a patient on the importance of booster doses to ensure optimal COVID-19 protection
• Explain the new pediatric indications and recommendations for COVID-19 vaccines
• Summarize long COVID ramifications on patients

Pour vous inscrire, allez au site Internet de mdBriefCase.

Watch the recording now to listen as Drs. Allison McGeer, Earl Rubin and David Strain, with moderator Dr. Peter Lin, address the following topics:

• Omicron (as it was evolving late November)
• Boosters
  • Mix & match (aka heterologous & homogenous vaccines)
  • Immunocompromised
  • Older adults
  • Practical considerations
• Vaccine Hesitancy
• Pediatric COVID vaccination

Pour vous inscrire, allez au site Internet de mdBriefCase.

This video helps clinicians discuss COVID-19 booster vaccination with their patients. The goal of the program is to help clinicians identify patients who should receive booster doses of the COVID-19 vaccines and to help build confidence in discussing booster vaccination with these patients.

Pour vous inscrire, allez au site Internet de mdBriefCase.

In 2021, Health Canada approved the use of the Pfizer-BioNTech COVID-19 vaccine in children 5-11 years of age. As this population continues to get vaccinated, clinicians need to be prepared to effectively discuss the benefits and risks of vaccination against COVID-19 with parents who have children within this age group.

Pour vous inscrire, allez au site Internet de mdBriefCase.

The National Advisory Committee on Immunization (NACI) recommends vaccination of adolescents aged 12 years and older with the COVID-19 vaccine. Despite broad support for vaccination from the medical community, parents and adolescents may have lingering concerns about COVID-19 vaccination. Pediatricians and other health professionals should be prepared to effectively address the questions and concerns of parents and adolescents regarding the COVID-19 vaccines.

Pour vous inscrire, allez au site Internet de mdBriefCase.

Did you know? An estimated 10–30% of patients experience long COVID after recovering from their initial infection. Register for our exclusive, 1-hour webinar and learn how to effectively diagnose and treat patients who show varying symptoms causing a range of health complications post COVID.

Pour vous inscrire, allez au site Internet de mdBriefCase.

mRNA vaccines have been transformational to the COVID-19 pandemic. They deliver the instructions to produce the spike protein of the SARS-CoV-2 virus to allow our immune system to mount an immune response and protect us from COVID-19. But mRNA vaccines are only one use of this technology. If the right mRNA is delivered to a specific site at the right time, it can help to address health conditions associated with a specific protein. This can lead to potential roles across multiple disease states. In this video, Dr. Melissa Moore, Chief Medical Officer of Moderna covers ten things that you should know about mRNA.

Pour vous inscrire, allez au site Internet de mdBriefCase.

With the COVID-19 virus rapidly evolving, patients must focus on maintaining their protection against COVID-19. Clinicians play an important role in educating their patients on how to remain protected from COVID-19, including remaining up to date with the recommended vaccinations and boosters. This brief video will provide healthcare professionals with a quick summary regarding the […]

Pour vous inscrire, allez au site Internet de mdBriefCase

With the evolving nature of COVID-19 in pediatrics, parents and caregivers may have questions about its clinical presentation and COVID vaccination. This expert brief includes discussions regarding the impact of the virus on children aged 6 months to 5 years, the efficacy and safety of the mRNA vaccines in children, and addresses common vaccine-related questions and myths.

Pour vous inscrire, allez au site Internet de mdBriefCase.

Influenza, pneumococcal disease, and COVID-19 are all serious, transmissible respiratory infections that can have life-threatening implications for high-risk individuals. But one thing they also have in common is that they are all vaccine-preventable.

Learn why taking a one, two, three approach to vaccines can help protect your patients at risk.

Following this webinar, you will be better able to:

• Describe the morbidity and mortality risk associated with COVID-19, influenza and pneumococcal infections.
• Determine which people are at elevated risk from these infections.
• Discuss strategies that can help lower the risk of these complications.

Implement strategies to increase vaccine uptake of these common adult vaccines in primary care.

Pour vous inscrire, allez au site Internet de mdBriefCase.